PEGylated apoptotic protein-loaded PLGA microspheres for cancer therapy

Hyeong Jun Byeon1 Department of Pharmaceutical Sciences, School of Pharmacy, Sungkyunkwan University, Suwon, Republic of Korea

Insoo Kim1 Department of Pharmaceutical Sciences, School of Pharmacy, Sungkyunkwan University, Suwon, Republic of Korea

Ji Su Choi1 Department of Pharmaceutical Sciences, School of Pharmacy, Sungkyunkwan University, Suwon, Republic of Korea

Eun Seong Lee2 Division of Biotechnology, The Catholic University of Korea, Bucheon-si, Republic of Korea

Beom Soo Shin3 Department of Pharmacy, College of Pharmacy, Catholic University of Daegu, Gyeongsan-si, Republic of Korea

Yu Seok Youn1 Department of Pharmaceutical Sciences, School of Pharmacy, Sungkyunkwan University, Suwon, Republic of KoreaCorrespondence[email protected]

Pages 739-748 | Published online: 19 Jan 2015

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

TalujaAYounYSBaeYHNovel approaches in microparticulate PLGA delivery systems encapsulating proteinsJ Mater Chem20071740024014
Web of Science ®Google Scholar
GuptaRKSinghMO’HaganDTPoly(lactide-co-glycolide) microparticles for the development of single-dose controlled-release vaccinesAdv Drug Deliv Rev199832322524610837646
PubMed Web of Science ®Google Scholar
Van de WeertMHenninkWEJiskootWProtein instability in poly(lactic-co-glycolic acid) microparticlesPharm Res200017101159116711145219
PubMed Web of Science ®Google Scholar
WischkeCSchwendemanSPPrinciples of encapsulating hydrophobic drugs in PLA/PLGA microparticlesInt J Pharm2008364229832718621492
PubMed Web of Science ®Google Scholar
PaiSSTiltonRDPrzybycienTMPoly(ethylene glycol)-modified proteins: implications for poly(lactide-co-glycolide)-based microsphere deliveryAAPS J2009111889819199044
PubMed Web of Science ®Google Scholar
FuKKlibanovAMLangerRProtein stability in controlled-release systemsNat Biotechnol2000181242510625383
PubMed Web of Science ®Google Scholar
DiwanMParkTGPegylation enhances protein stability during encapsulation in PLGA microspheresJ Control Release2001732–323324411516501
PubMed Web of Science ®Google Scholar
DiwanMParkTGStabilization of recombinant interferon-alpha by pegylation for encapsulation in PLGA microspheresInt J Pharm20032521–211112212550786
PubMed Web of Science ®Google Scholar
HindsKDCampbellKMHollandKMLewisDHPichéCASchmidtPGPEGylated insulin in PLGA microparticles. In vivo and in vitro analysisJ Control Release2005104344746015911045
PubMed Web of Science ®Google Scholar
GriffithTSLynchDHTRAIL: a molecule with multiple receptors and control mechanismsCurr Opin Immunol19981055595639794836
PubMed Web of Science ®Google Scholar
LeBlancHNAshkenaziAApo2L/TRAIL and its death and decoy receptorsCell Death Differ2003101667512655296
PubMed Web of Science ®Google Scholar
FrenchLETschoppJThe TRAIL to selective tumor deathNat Med1999521461479930856
PubMed Web of Science ®Google Scholar
AshkenaziAPaiRCFongSSafety and antitumor activity of recombinant soluble Apo2 ligandJ Clin Invest1999104215516210411544
PubMed Web of Science ®Google Scholar
ThomasRPFarrowBJKimSMayMJHellmichMREversBMSelective targeting of the nuclear factor-kappaB pathway enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated pancreatic cancer cell deathSurgery2002132212713412219002
PubMed Web of Science ®Google Scholar
OzawaFFriessHKleeffJEffects and expression of TRAIL and its apoptosis-promoting receptors in human pancreatic cancerCancer Lett20011631718111163110
PubMed Web of Science ®Google Scholar
SaitoRBringasJRPannerAConvection-enhanced delivery of tumor necrosis factor-related apoptosis-inducing ligand with systemic administration of temozolomide prolongs survival in an intracranial glioblastoma xenograft modelCancer Res200464196858686215466173
PubMed Web of Science ®Google Scholar
RothWIsenmannSNaumannULocoregional Apo2L/TRAIL eradicates intracranial human malignant glioma xenografts in athymic mice in the absence of neurotoxicityBiochem Biophys Res Commun1999265247948310558893
PubMed Web of Science ®Google Scholar
KimTHYounYSJiangHHLeeSChenXLeeKCPEGylated TNF-related apoptosis-inducing ligand (TRAIL) analogues: pharmacokinetics and antitumor effectsBioconjug Chem20112281631163721751817
PubMed Web of Science ®Google Scholar
ChaeSYKimTHParkKImproved antitumor activity and tumor targeting of NH(2)-terminal-specific PEGylated tumor necrosis factor-related apoptosis-inducing ligandMol Cancer Ther2010961719172920515949
PubMed Web of Science ®Google Scholar
YounYSNaDHYooSDSongSCLeeKCCarbohydrate-specifically polyethylene glycol-modified ricin A-chain with improved therapeutic potentialInt J Biochem Cell Biol20053771525153315833282
PubMed Web of Science ®Google Scholar
HarrisJMMartinNEModiMPegylation: a novel process for modifying pharmacokineticsClin Pharmacokinet200140753955111510630
PubMed Web of Science ®Google Scholar
JiangHHKimTHLeeSChenXYounYSLeeKCPEGylated TNF-related apoptosis-inducing ligand (TRAIL) for effective tumor combination therapyBiomaterials201132338529853721855130
PubMed Web of Science ®Google Scholar
KimTHJiangHHParkCWPEGylated TNF-related apoptosis-inducing ligand (TRAIL)-loaded sustained release PLGA microspheres for enhanced stability and antitumor activityJ Control Release20111501636921062635
PubMed Web of Science ®Google Scholar
LimSMKimTHJiangHHImproved biological half-life and anti-tumor activity of TNF-related apoptosis-inducing ligand (TRAIL) using PEG-exposed nanoparticlesBiomaterials201132133538354621306770
PubMed Web of Science ®Google Scholar
BaeSMaKKimTHDoxorubicin-loaded human serum albumin nanoparticles surface-modified with TNF-related apoptosis-inducing ligand and transferrin for targeting multiple tumor typesBiomaterials20123351536154622118776
PubMed Web of Science ®Google Scholar
YounYSShinMJChaeSYJinCHKimTHLeeKCBiological and physicochemical evaluation of the conformational stability of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)Biotechnol Lett200729571372117318333
PubMed Web of Science ®Google Scholar
ByeonHJChoiSHChoiJSFour-arm PEG cross-linked hyaluronic acid hydrogels containing PEGylated apoptotic TRAIL protein for treating pancreatic cancerActa Biomater20141014215024021228
PubMed Web of Science ®Google Scholar
YanBMVan DamJEndoscopic ultrasound-guided intratumoural therapy for pancreatic cancerCan J Gastroenterol200822440541018414717
PubMed Web of Science ®Google Scholar
VernaECDharVEndoscopic ultrasound-guided fine needle injection for cancer therapy: the evolving role of therapeutic endoscopic ultrasoundTherap Adv Gastroenterol200812103109
Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

PEGylated apoptotic protein-loaded PLGA microspheres for cancer therapy

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

PEGylated apoptotic protein-loaded PLGA microspheres for cancer therapy

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date